Testing effectiveness (Phase 2)Active Not RecruitingNCT05053152
What this trial is testing
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
Who this might be right for
Oligometastatic Prostate CarcinomaProstate AdenocarcinomaProstate Ductal Adenocarcinoma+2 more
NRG Oncology 194